ARTICLE | Top Story
NRP104 meets Phase III endpoints
May 24, 2005 12:44 AM UTC
New River (NRPH) said its NRP104 met the primary endpoint of ADHD rating scale (ADHD-RS) and the secondary endpoint of Conners' Parent scale in a placebo-controlled Phase III trial to treat ADHD in 28...